Strategic Decoy Peptides Interfere with MSI1/AGO2 Interaction to Elicit Tumor Suppression Effects

SIMPLE SUMMARY: Peptide drugs that can specifically target undesirable protein–protein interactions that lead to oncogenic developments have emerged as the next era of future medicine for cancers. To combat GBM tumor progression, our study offers an alternative therapeutic strategy via targeting the...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Yi-Ping, Lee, Andy Chi-Lung, Lin, Liang-Ting, Chen, Yi-Wei, Huang, Pin-I, Ma, Hsin-I, Chen, Yi-Chen, Lo, Wen-Liang, Lan, Yuan-Tzu, Fang, Wen-Liang, Wang, Chien-Ying, Liu, Yung-Yang, Hsu, Po-Kuei, Lin, Wen-Chang, Li, Chung-Pin, Chen, Ming-Teh, Chien, Chian-Shiu, Wang, Mong-Lien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833744/
https://www.ncbi.nlm.nih.gov/pubmed/35158774
http://dx.doi.org/10.3390/cancers14030505

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833744/
https://www.ncbi.nlm.nih.gov/pubmed/35158774
http://dx.doi.org/10.3390/cancers14030505

Ejemplares similares